These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 4610921)
21. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody. Guttmann RD; Lindquist RR; Ockner SA; Merrill JP Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260 [No Abstract] [Full Text] [Related]
22. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients. Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906 [No Abstract] [Full Text] [Related]
23. Rejection of renal allografts: specific immunologic suppression. Stuart FP; Saitoh T; Fitch FW Science; 1968 Jun; 160(3835):1463-5. PubMed ID: 4871383 [TBL] [Abstract][Full Text] [Related]
24. The capacity of lymphocytes from rats bearing enhanced kidney allografts to mount graft-versus-host reactions. French ME; Batchelor JR; Watts HG Transplantation; 1971 Jul; 12(1):45-8. PubMed ID: 4397366 [No Abstract] [Full Text] [Related]
25. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors. Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952 [No Abstract] [Full Text] [Related]
26. The effect of sheep antilymphocyte plasma on the survival of dog renal allografts. Fox M; Diethelm AG; Orr WM; Dammin GJ; Glassock RJ; Murray JE Proc R Soc Med; 1968 Sep; 61(9):877-80. PubMed ID: 4878256 [No Abstract] [Full Text] [Related]
27. Enhancement of skin allograft survival by soluble alloantigen is serum-mediated. Rao VS; Bonavida B Transplantation; 1976 Jan; 21(1):42-50. PubMed ID: 1108325 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization. Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465 [No Abstract] [Full Text] [Related]
31. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts. Strom TB; Carpenter CB; Garovoy MR; Abbas AK; Corson JM; Bear RA; Soulillou JP Transplantation; 1975 Nov; 20(5):368-80. PubMed ID: 1108311 [TBL] [Abstract][Full Text] [Related]
32. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125 [No Abstract] [Full Text] [Related]
33. Hyperacute rejection and enhancement of rabbit-kidney allografts. McDowall RA; Batchelor JR; French ME Lancet; 1973 Apr; 1(7807):797-801. PubMed ID: 4121222 [No Abstract] [Full Text] [Related]